|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities: | |||||
| Depreciation | |||||
| Provision for credit losses | |||||
| Net (gain) loss on sale and write down of other real estate owned | |||||
| Amortization of loan servicing rights | |||||
| Net change in loan servicing rights valuation allowance | |||||
| Loans originated for sale, including participations | |||||
| Net gain on sales of loans | |||||
| Proceeds from sale of loans, including participations | |||||
| Net gain on Visa shares | |||||
| Net loss on sale of premises and equipment | |||||
| Net loss on sales and calls of securities available-for-sale | |||||
| Net securities amortization | |||||
| Stock based compensation expense | |||||
| Earnings on life insurance | |||||
| Gain on life insurance | |||||
| Tax (benefit) expense of stock award issuances | |||||
| Net change: | |||||
| Interest receivable and other assets | |||||
| Interest payable and other liabilities | |||||
| Total adjustments | |||||
| Net cash from operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of securities available-for-sale | |||||
| Proceeds from sales of Visa shares | |||||
| Proceeds from maturities, calls and principal paydowns of securities available-for-sale | |||||
| Proceeds from maturities, calls and principal paydowns of securities held-to-maturity | |||||
| Purchases of securities available-for-sale | |||||
| Purchase of life insurance | |||||
| Net (increase) decrease in total loans | |||||
| Proceeds from sales of land, premises and equipment | |||||
| Purchases of land, premises and equipment | |||||
| Proceeds from redemption of Federal Home Loan Bank stock | |||||
| Purchases of Federal Home Loan Bank stock | |||||
| Proceeds from sales of other real estate owned | |||||
| Proceeds from life insurance | |||||
| Net cash from investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase in total deposits | |||||
| Net increase (decrease) in other borrowings | |||||
| Payments on short-term FHLB borrowings | |||||
| Payments on short-term FHLB borrowings,net | |||||
| Proceeds from short-term FHLB borrowings | |||||
| Payments on long-term FHLB borrowings | |||||
| Proceeds from (payments on) short-term FHLB borrowings, net | |||||
| Proceeds from long-term FHLB borrowings | |||||
| Common dividends paid | |||||
| Preferred dividends paid | |||||
| Payments related to equity incentive plan | |||||
| Purchase of treasury stock | |||||
| Sales of treasury stock | |||||
| Net cash from financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Cash and cash equivalents at end of the year | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| Income taxes | |||||
| Supplemental non-cash disclosures: | |||||
| Loans transferred to other real estate owned | |||||
| Property transferred to held-for-sale | |||||
| Right-of-use assets obtained in exchange for lease liabilities | |||||
Loading...